|
|
||||||||
Letters to the Editor |
1 Bayer HealthCare, Diagnostics Division, Walpole, MA, Bayer HealthCare
2 Diagnostics Division, and
3 Diabetes Care Division, Tarrytown, NY
aAddress correspondence to this author at: Bayer HealthCare, Diagnostics Division, 333 Coney St., Walpole, MA 02032. Fax 508-660-4500; e-mail david. waskiewicz.b{at}bayer.com.
To the Editor:
A recent report in this journal by Rawlins and Roberts (1) compared 6 commercial third-generation assays for thyroid-stimulating hormone (TSH). The authors reported a functional sensitivity of 0.039 mIU/L for the ADVIA Centaur® TSH-3, in contrast to the manufacturers claim of 0.019 mIU/L (2). Rawlins and Roberts (1) cited a single earlier ADVIA Centaur study (3), which they claim agrees with their results; however, the cited study actually evaluated the ADVIA Centaur TSH, a second-generation TSH assay that is different from the TSH-3. Previous publications on the ADVIA Centaur TSH-3 reported functional sensitivities in the range of 0.0180.025 mIU/L (4)(5)(6) and are in general agreement with the manufacturers claim. We investigated further to resolve the apparent inconsistencies raised by Rawlins and Roberts (1).
We conducted a new evaluation of the functional sensitivity of the ADVIA Centaur TSH-3. Included were the same two lots used by Rawlins and Roberts (lots 26 and 29), which now had been expired for 89 months, as well as two in-date lots (lots 38 and 41). The method closely followed that of Rawlins and Roberts (1). Serum samples were used to prepare 8 patient pools distributed within the TSH-3 dose range of
0.010.15 mIU/L.
Pools were tested on one ADVIA Centaur with each TSH-3 lot in duplicate, twice per week, for 3 weeks, for a total of 12 replicates. Each pool was tested with all TSH-3 reagent lots in one run to allow all results to be generated within several minutes. The Centaur was a routine production system used for various assay and patient sample evaluations in support of Centaur customers. Functional sensitivity was determined by plotting the total CV for each of the 8 pools as a function of TSH dose. The data were fit with a power equation of the form Total CV = a(TSH dose)b, and functional sensitivity was calculated to be the dose in the equation with a total CV of 20%. We found the functional sensitivity, using reagent lots 26 and 29, to be 0.012 mIU/L. This value is considerably lower than that of Rawlins and Roberts (1), although the same reagent lots were used. For the two newer in-date lots, functional sensitivity was calculated to be 0.022 mIU/L. Both determinations are consistent with the manufacturers claim of 0.019 mIU/L for the ADVIA Centaur TSH-3.
In summary, we believe that the data support our functional sensitivity claim for the third-generation ADVIA Centaur TSH-3 method and that this claim has been demonstrated in other studies (4)(5)(6).
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |